ACE and Alzheimer disease: It is possible that the ACE overexpressing monocytes, not only increase expression of this important proteolytic enzyme but also exhibit a distinct anti-inflammatory and neuroprotective phenotype that may prove to be a powerful tool in ameliorating AD pathogenesis.